Vireo Growth Inc. has taken a significant step forward in its planned merger with Planet 13 Holdings Inc. by filing an amended registration statement with the Securities and Exchange Commission (SEC). This move comes as part of the ongoing efforts to finalize the merger agreement announced earlier this year. The merger is poised to reshape the competitive dynamics within the pharmaceutical preparations industry, particularly in the cannabis sector.

Vireo Growth, listed on the OTC under the ticker VREOF, is a company focused on the production and distribution of cannabis products. The company operates in the pharmaceutical preparations sector, as indicated by its SIC code 2834. Vireo has undergone several name changes in its history, previously known as Goodness Growth Holdings, Inc. and Vireo Health International, Inc. The company is incorporated in British Columbia, Canada, and has its headquarters in Minneapolis, Minnesota.

The recent SEC filing, accession number 0001104659-26-120675, details the merger agreement between Vireo Growth and Planet 13, which is set to be voted on by Planet 13 stockholders at a special meeting scheduled for December 10, 2026. If approved, the merger will see Planet 13 stockholders receive subordinate voting shares of Vireo Growth in exchange for their shares. Specifically, the exchange ratio is set at 0.015383618 of a subordinate voting share of Vireo Growth for each share of Planet 13 common stock held.

According to the filing, the merger cannot proceed without the approval of the merger proposal by a majority of Planet 13's stockholders. This includes both the affirmative vote of the holders of a majority of the outstanding shares and a simple majority of the votes cast, excluding shares held by certain founders and affiliates. The Planet 13 board of directors has unanimously recommended that stockholders vote in favor of the merger.

The merger is expected to significantly impact both companies and their respective shareholders. Current Vireo Growth shareholders as of October 29, 2026, will own approximately 90.62% of the outstanding subordinate voting shares following the merger, while Planet 13 stockholders will hold about 9.38% of the shares. This consolidation could enhance Vireo's market position and operational capabilities within the cannabis and pharmaceutical preparations industry.

Looking ahead, the upcoming special meeting on December 10 will be crucial for the merger's success. Planet 13 stockholders are encouraged to participate in the voting process, either virtually or by proxy, to ensure their voices are heard regarding this significant transaction. The filing does not specify any further actions beyond this vote, but the outcome will determine the future trajectory of both Vireo Growth and Planet 13.